Dec. 4, 2002 (Chicago) - A radiopharmaceutical-imaging agent - ioflupane (I123-FP-CIT) - used with single photon emission computed tomography (SPECT) is "98% accurate" for early diagnosis of Parkinson ...
Reston, VA—A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized ...
Chengdu Brilliant Pharmaceutical Co. Ltd. and Chengdu Xinke Pharmaceutical Co. Ltd. have disclosed drug conjugates comprising a bone-targeting moiety covalently bound to a radiolabeled-chelating agent ...
Reston, VA (October 13, 2025)--A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during ...
The partnership expands DocGo’s ability to support patients and vulnerable populations NEW YORK--(BUSINESS WIRE)-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of ...
Healthcare Asia Magazine on MSN
Amrita Hospital introduces low-radiation SPECT/CT imaging technology
The technology supports clinical applications, including oncology, amongst others. Amrita Hospital has inaugurated the next-generation Symbia Pro.specta SPECT/CT system in the Department of Nuclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results